Skip to main content
Physiatry '25 Main banner
Final Program


Final Program

694 - Quantifying the Strain: A Global Burden of Disease (GBD) Perspective on Musculoskeletal Disorders in the United States Over Three Decades, 1990 - 2019

Thursday, February 27, 2025
5:00 PM - 6:30 PM MST

    Presenting Author(s)

  • YA

    Yazan Al-Ajlouni, MD

    Resident Doctor
    Staten Island University Hospital, Northwell Health
    Brooklyn, New York, United States

    • Co-Author(s)

  • OT

    Omar Ta’ani, MD

    Resident Doctor
    Alleghany Health
    Pittsburgh, Pennsylvania, United States

  • sz

    sophia A. zweig, BS

    Medical Student
    Downstate SUNY
    Brooklyn, New York, United States

  • AG

    Ahmed Gabr, BA

    Medical Student
    New York Medical College
    Staten Island, New York, United States

  • GN

    Godstime Nwatu Ugwu, BS

    Medical Student
    Downstate SUNY
    Brooklyn, New York, United States

  • ZA

    Zaid Al Ta'ani, MD

    Physician
    University of Jordan Hospital
    AMman, 'Amman, Jordan

    • Corresponding Author(s)

  • MI

    Mohammad S. Islam, MD

    Attending Doctor
    New York Medical College/ Metropolitan Hospital
    New York, New York, United States

Objectives: Musculoskeletal (MSK) disorders significantly contribute to global disability, especially in high-income countries. Yet, comprehensive studies on their epidemiological burden in the United States (US) are limited. Our study aims to fill this gap by characterizing the MSK disease burden in the US using Global Burden of Disease (GBD) data from 1990-2019.

Design:

We conducted an ecological study using descriptive statistical analyses to examine age-standardized prevalence and disability-adjusted life years (DALY) rates of MSK disorders across different demographics and states. The study also assessed the impact of risk factors segmented by age and gender.

Results:

From 1990 to 2019, the burden of MSK disorders in the US increased significantly. Low back pain was the most prevalent condition. Age-standardized prevalence and DALY rates increased by 6.7% and 17.6%, respectively. Gout and other MSK disorders saw the most significant rise in DALY rates. Women experienced higher rates than men, and there were notable geographic disparities, with the District of Columbia having the lowest and North Dakota and Iowa the highest DALY rates. Smoking, high BMI, and occupational risks emerged as primary risk factors.

Conclusions:

Our study highlights the escalating burden of MSK disorders in the US, revealing significant geographic and gender disparities. These findings highlight the urgent need for targeted health interventions, policy formulation, and public health initiatives focusing on lifestyle and workplace modifications. Region and gender-specific strategies are crucial in effectively managing MSK conditions, considering the influence of various risk factors.